Format

Send to

Choose Destination
Clin Infect Dis. 2006 Aug 1;43(3):312-4. Epub 2006 Jun 23.

Rotavirus serotype G9 is associated with more-severe disease in Latin America.

Author information

1
Instituto Evandro Chagas, Secretaria de Vigilância em Saúde, Ministério da Saúde, Belém, Brazil. alexandrelinhares@iec.pa.gov.br

Abstract

The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.

PMID:
16804845
DOI:
10.1086/505493
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center